1-20 of 102
Hun Ju Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma

Alexandra Elias, Mario L. Marques-Piubelli, Ranjit Nair, Rishab Prakash, Sairah Ahmed, Luis Malpica, Hun Ju Lee, Jie Xu, Christopher R. Flowers, Sattva S. Neelapu, Francisco Vega, Roberto Miranda, Swami P. Iyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1714.
https://doi.org/10.1182/blood-2023-187939
Published: 2023
Journal Articles

Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy

Matthew G. Mei, Gaetano Corazzelli, Frank Morschhauser, Elizabeth Phillips, Graham P. Collins, Hun Ju Lee, Steve M Ansell, Craig H. Moskowitz, Nathalie A. Johnson, John Kuruvilla, Martin Hutchings, María José Terol Castera, George Hawkins, Anna Vossenkaemper, Teresa Collins, Robin Lesley, Emma Dean, Ting Yu, Connor Hall, Virginie Cerec, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2023-180926
Published: 2023
Journal Articles

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Preetesh Jain, Hun Ju Lee, Jason Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair, Swami P. Iyer, Rashmi Kanagal-Shamanna, Ahmed Fetooh, Holly A Hill, Chi Young Ok, Wendy Chen, Onyeka Oriabure, Lei Feng, Guilin Tang, Francisco Vega, Maria Badillo, Christopher R. Flowers, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1688.
https://doi.org/10.1182/blood-2023-181312
Published: 2023
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced Stage Classical Hodgkin Lymphoma: Efficacy and Safety Results from the Single Arm Phase 2 Study

Hun Ju Lee, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Paul Alan Gonzales, Mihir Raval, Rangaswamy Chintapatla, Tatyana Feldman, Habte A. Yimer, Miguel Islas-Ohlmayer, Asad Dean, Vishal Rana, Mitul Gandhi, John Scott Renshaw, Linda Ho, Michelle A. Fanale, Wenchuan Guo, Chris Yasenchak
Journal: Blood
Blood (2023) 142 (Supplement 1): 608.
https://doi.org/10.1182/blood-2023-173972
Published: 2023
Journal Articles

Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial

Preetesh Jain, Chi Young OK, Loretta J. Nastoupil, Jason Westin, Holly A Hill, Ranjit Nair, Swami P. Iyer, Ahmed Fetooh, Hun Ju Lee, Sairah Ahmed, Rashmi Kanagal-Shamanna, Fatima Z Jelloul, Luis Enrique Malpica Castillo, Yang Liu, Yijing Li, Jovanny Vargas, Lei Feng, Maria Badillo, Selvi Thirumurthi, Guofan Xu, Anita Deswal, Cezar Iliescu, Vinh Quang Nguyen, Guilin Tang, Keyur P. Patel, Francisco Vega, L. Jeffrey Medeiros, Michael L. Wang, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 3036.
https://doi.org/10.1182/blood-2023-181216
Published: 2023
Journal Articles

Phase II Trial of Ibrutinib in Previously Untreated High-Risk Smoldering Mantle Cell Lymphoma

Charles Gaulin, Preetesh Jain, Ranjit Nair, Swami P. Iyer, Hun Ju Lee, Luis Fayad, Lei Feng, Yang Liu, Holly A Hill, Yijing Li, Chi Young Ok, Rashmi Kanagal-Shamanna, Onyeka Oriabure, Wendy Chen, Asiya Siddiqui, Guofan Xu, Anita Deswal, Cezar Iliescu, Maria Badillo, Shaoying Li, Michelle Ky, Michelle Avellaneda, Guilin Tang, Francisco Vega, Christopher R. Flowers, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3034.
https://doi.org/10.1182/blood-2023-187903
Published: 2023
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early-Stage Classical Hodgkin Lymphoma (SGN35-027 Part C)

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C Lynch, Eva Domingo Domenech, Brian Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Linda Ho, Rose C. Beck, Christopher A. Yasenchak, Hun Ju Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 611.
https://doi.org/10.1182/blood-2023-172574
Published: 2023
Journal Articles

Outcomes in Patients with Relapsed Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with CAR-T Cell Therapies or Salvage Chemotherapy - a Single-Institution Experience

Ranjit Nair, Iyanuoluwa Ogundipe, Jillian Gunther, L. Jeffrey Medeiros, Preetesh Jain, Loretta J. Nastoupil, Chelsea Camille Pinnix, Luis Malpica, Sairah Ahmed, Roberto Miranda, Luis Fayad, Raphael E Steiner, Frederick Hagemeister, Hun Ju Lee, Maria Alma Rodriguez, Paolo Strati, Dai Chihara, Michael Wang, Yago Nieto, Jeremy Ramdial, Ajlan Al Zaki, Chijioke Nze, Michael R. Green, Bouthaina S. Dabaja, Jie Xu, Beenu Thakral, Sattva S. Neelapu, Francisco Vega, Christopher R. Flowers, Penny Fang, Jason Westin, Lei Feng, Swami P. Iyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 6327.
https://doi.org/10.1182/blood-2023-191096
Published: 2023
Journal Articles

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

Clinical Trials & Observations
Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Alex F. Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H. Moskowitz
Journal: Blood
Blood (2023) 142 (10): 878–886.
https://doi.org/10.1182/blood.2022019386
Published: 2023
Includes: Supplemental data
Journal Articles

Risk of Pneumonitis with Immune Checkpoint Inhibitors in Hodgkin's Lymphoma and Other Hematologic Malignancies: A Retrospective Review from Pharmacovigilance

Ugochi Ebinama, Ajay Sheshadiri, Sairah Ahmed, Hun Ju Lee, Meng Liu, Swaminathan Padmanabhan Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 5183–5184.
https://doi.org/10.1182/blood-2022-165698
Published: 2022
Journal Articles

Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)

Hun Ju Lee, Michael Y. Choi, Tanya Siddiqi, Joanna M. Rhodes, William G. Wierda, Iris Isufi, Joseph M Tuscano, Nicole Lamanna, Suki Subbiah, Jean L. Koff, Lori Leslie, Alec Goldenberg, Gina G Chung, James B. Breitmeyer, Salim Yazji, Michael Wang, Catriona Jamieson, Thomas J. Kipps
Journal: Blood
Blood (2022) 140 (Supplement 1): 566–568.
https://doi.org/10.1182/blood-2022-167153
Published: 2022
Journal Articles

Nivolumab Plus ICE As First Salvage Therapy in High-Risk Relapsed/Refractory Hodgkin Lymphoma

Matthew Mei, Joycelynne Palmer, Ni-Chun Tsai, Hun Ju Lee, Iris Isufi, Leslie L. Popplewell, Lynne Smith, Lacolle Peters, Lara Rodriguez, James Godfrey, John H. Baird, Joo Y. Song, Steven T. Rosen, Larry W. Kwak, Stephen J Forman, Alex F. Herrera
Journal: Blood
Blood (2022) 140 (Supplement 1): 774–776.
https://doi.org/10.1182/blood-2022-167626
Published: 2022
Journal Articles

Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.

Ranjit Nair, Rishab Prakash, Anna Dang, Jillian R. Gunther, Auris Huen, Jie Xu, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Meghan Heberton, Penny Fang, Sairah Ahmed, Roberto N. Miranda, Luis Fayad, Raphael Steiner, Hun Ju Lee, Dai Chihara, Preetesh Jain, Samer A Srour, Jeremy L Ramdial, Yago Nieto, Loretta J. Nastoupil, Chelsea C. Pinnix, Sattva S. Neelapu, Christopher R. Flowers, L. Jeffrey Medeiros, Chitra Hosing, Michael L. Wang, Bouthaina S. Dabaja, Francisco Vega, Lei Feng, Swaminathan Padmanabhan Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 12005–12007.
https://doi.org/10.1182/blood-2022-170750
Published: 2022
Journal Articles

Mutation Spectrum, Characteristics and Impact of Mutation Profiling on Prognosis, Outcome and Treatment Responses in Patients (pts) with Mantle Cell Lymphoma

Preetesh Jain, Chi Young Ok, Ahmed Fetooh, Rashmi Kanagal-Shamanna, Fatima Zahra Jelloul, Holly Hill, Kristen Floyd, Sanam Loghavi, Zhuang Zuo, C. Cameron Yin, Mark Routbort, Guilin Tang, Sairah Ahmed, Luis Enrique Malpica Castillo, Asiya Siddiqui, Wendy Chen, Onyeka Oriabure, Maria Badillo, Raphael E Steiner, Swaminathan P. Iyer, Hun Ju Lee, Rajyalakshmi Luthra, Francisco Vega, Christopher R. Flowers, Jeffrey Medeiros, Michael L. Wang, Keyur P. Patel, Nathan H. Fowler, Ranjit Nair
Journal: Blood
Blood (2022) 140 (Supplement 1): 3598–3600.
https://doi.org/10.1182/blood-2022-162806
Published: 2022
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early Stage Classic Hodgkin Lymphoma: Interim Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part C)

Hun Ju Lee, Jeremy S. Abramson, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Domingo Domenech Eva, Brian T. Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Giuseppe Rossi, Uwe H Hahn, Henry Miles Prince, Linda Ho, Wenchuan Guo, Christopher A. Yasenchak, David J. Straus
Journal: Blood
Blood (2022) 140 (Supplement 1): 9399–9401.
https://doi.org/10.1182/blood-2022-156576
Published: 2022
Journal Articles

Prognostic Value of Body Composition in a Cohort of Elderly Pts with Newly Diagnosed Classical Hodgkin's Lymphoma: A Retrospective Single Center Study

Serageldin Kamel, Joo Schmidt, Eslam Aboismail, Lucia L Martini, Sairah Ahmed, Ranjit Nair, Raphael E Steiner, Michael L. Wang, Gregory Ravizzini, Sarita Soebianto, Tinsu Pan, Jillian R. Gunther, Chelsea C. Pinnix, Hun Ju Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 13020–13022.
https://doi.org/10.1182/blood-2022-171186
Published: 2022
Journal Articles

Frontline PET-Directed Therapy with Brentuximab Vedotin Plus AVD Followed By Nivolumab Consolidation in Patients with Limited Stage Hodgkin Lymphoma

Steven I. Park, Stephen M. Ansell, Sharmila Giri, Jakub Svoboda, Stephen D Smith, Tatyana Feldman, Elizabeth L. Budde, Andrew J Ness, Yunsik Choi, Philip J Bierman, Hun Ju Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 1751–1752.
https://doi.org/10.1182/blood-2022-159258
Published: 2022
Journal Articles

Phase II Study of Pembrolizumab and Fractionated External Beam Radiotherapy in Patients with Relapsed and Refractory Large B-Cell Lymphoma

Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Penny Fang, Susan Wu, Sairah Ahmed, Raphael E Steiner, Ranjit Nair, Paolo Strati, Jason Westin, Luis Fayad, Swami P. Iyer, Maria Alma Rodriguez, Hun Ju Lee, Felipe Samaniego, Dai Chihara, Preetesh Jain, Lei Feng, Christopher R. Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood
Blood (2022) 140 (Supplement 1): 3741–3743.
https://doi.org/10.1182/blood-2022-168540
Published: 2022
Journal Articles

CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL

Ranjit Nair, Amy Ayers, Loretta J. Nastoupil, Jillian R. Gunther, Luis Fayad, Nathan H. Fowler, Roberto N. Miranda, Fredrick B. Hagemeister, Hun Ju Lee, Maria Alma Rodriguez, Raphael Steiner, Paolo Strati, Yago Nieto, Jeremy L. Ramdial, Dai Chihara, Michael L. Wang, Luis E Malpica Castillo, Neeraj Saini, Preetesh Jain, Chelsea C. Pinnix, Bouthaina S. Dabaja, Michael R Green, Christopher R. Flowers, L. Jeffrey Medeiros, Mario L. Marques-Piubelli, Francisco Vega, Mansoor Noorani, Sairah Ahmed, Jason Westin, Sattva S. Neelapu, Lei Feng, Swaminathan Padmanabhan Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 3800–3802.
https://doi.org/10.1182/blood-2022-171120
Published: 2022
Journal Articles

Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis

Owhofasa O. Agbedia, Rishab Prakash, Jie Xu, Melody R. Becnel, Ranjit Nair, Raphael E Steiner, Lei Feng, Hun Ju Lee, Paolo Strati, Sairah Ahmed, Simrit Parmar, Yago Nieto, Chitra Hosing, Jason Westin, Loretta J. Nastoupil, Ann Vo, Felipe Samaniego, Nathan H. Fowler, Neeraj Saini, Issa F. Khouri, Jin S. Im, Luis Fayad, Preetesh Jain, Michael L. Wang, Roberto N. Miranda, Francisco Vega, Jeffrey Medeiros, Yasuhiro Oki, Christopher R. Flowers, Sattva S. Neelapu, Swaminathan P. Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2313–2315.
https://doi.org/10.1182/blood-2022-168983
Published: 2022